ANIP 总负债历史(2016–2025)
ANI Pharmaceuticals, Inc. (ANIP) 各财年年末总负债(来自 SEC 财报)。
$899.7MFY2025 · FY2016 以来:$153.2M → $899.7M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $899.7M | +5.1% |
| FY2024 | $855.9M | +91.6% |
| FY2023 | $446.8M | +6.0% |
| FY2022 | $421.5M | +2.1% |
| FY2021 | $412.9M | +55.5% |
| FY2020 | $265.5M | +8.8% |
| FY2019 | $244.0M | +4.6% |
| FY2018 | $233.3M | -1.7% |
| FY2017 | $237.4M | +54.9% |
| FY2016 | $153.2M | — |
公司未直接申报总负债的年份,按同一财年年末的申报总资产 − 申报股东权益列示。
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议